Abstract
The status of regulatory audits of clinical trials in the European Community (EC), Japan, the Nordic Council, and the United States is covered in this paper. Clinical research auditing is considered from two perspectives: 1) regulatory authority attitudes to sponsor auditing and regulatory audit/inspection activities and 2) sponsor audits in general and with special reference to CIBA-GEIGY's organization.
Get full access to this article
View all access options for this article.